Indrayani Biotech Limited (BOM:526445)
15.15
-0.22 (-1.43%)
At close: Oct 17, 2025
Indrayani Biotech Revenue
Indrayani Biotech had revenue of 295.54 million INR in the quarter ending June 30, 2025, a decrease of -33.41%. This brings the company's revenue in the last twelve months to 1.28 billion, down -22.84% year-over-year. In the fiscal year ending March 31, 2025, Indrayani Biotech had annual revenue of 1.3 billion, down -21.66%.
Revenue (ttm)
1.28B
Revenue Growth
-22.84%
P/S Ratio
0.54
Revenue / Employee
1.37M
Employees
936
Market Cap
689.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.30B | -359.97M | -21.66% |
Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
Mar 31, 2021 | 211.91M | -287.06M | -57.53% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
Life Insurance Corporation of India | 9,038.65B |
State Bank of India | 3,503.84B |
HDFC Bank | 2,736.06B |
Larsen & Toubro | 2,688.02B |
Tata Consultancy Services | 2,576.88B |
ICICI Bank | 2,054.85B |
Bharti Airtel | 1,839.41B |